Trials / Conditions / Oral Complications

Oral Complications

23 registered clinical trials studyying Oral Complications.

Status	Trial	Sponsor	Phase
Completed	Oral Care Frequency in Mechanically Ventilated Patients NCT05039593	Aydin Adnan Menderes University	N/A
Terminated	Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kid NCT02273752	Emory University	Phase 2
Completed	Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metast NCT02015559	Jonsson Comprehensive Cancer Center	Phase 2
Completed	Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoi NCT02123511	Mayo Clinic	Phase 2
Completed	Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute NCT01085617	University College, London	—
Completed	Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation NCT00080873	Children's Oncology Group	N/A
Completed	Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck C NCT00036881	Alliance for Clinical Trials in Oncology	Phase 3
Unknown	Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiat NCT00036712	Medical College of Wisconsin	Phase 2
Terminated	Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Canc NCT00025298	European Organisation for Research and Treatment of Cancer - EORTC	Phase 2
Completed	Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer NCT00017511	Daiichi Sankyo	Phase 3
Completed	Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer NCT00008398	Radiation Therapy Oncology Group	Phase 3
Completed	Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer NCT00004132	Jonsson Comprehensive Cancer Center	Phase 2
Completed	Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx NCT00004234	NCIC Clinical Trials Group	Phase 3
Completed	Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell T NCT00004061	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation NCT00003898	Roswell Park Cancer Institute	Phase 2
Completed	Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer NCT00003313	Radiation Therapy Oncology Group	Phase 3
Completed	Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanc NCT00003580	University of Tennessee	Phase 2
Terminated	Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids NCT00003686	NCIC Clinical Trials Group	Phase 3
Completed	Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Ca NCT00003139	Radiation Therapy Oncology Group	Phase 3
Completed	Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or S NCT00003193	Massachusetts General Hospital	Phase 1 / Phase 2
Completed	Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer NCT00004256	Royal Marsden NHS Foundation Trust	Phase 2
Completed	Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation NCT00024037	Fred Hutchinson Cancer Center	Phase 2 / Phase 3
Completed	Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer NCT00002533	University of Miami	Phase 2 / Phase 3